Revenue and EBITDA Growth
Revenue increased by 5.4% to GBP 673.2 million, with adjusted EBITDA rising by 9.4% to GBP 134.6 million, demonstrating strong financial performance.
Successful Acquisitions in Australia
Completed 7 practice acquisitions in Australia, expanding the footprint to 51 sites, with a strong pipeline for further growth.
Improved Cash Flow and Leverage
Adjusted operating cash conversion was 76.9%, surpassing the target of 70%. The year ended with leverage at 1.18x.
Positive Outlook for Future Growth
Confidence in achieving 4% to 8% like-for-like growth in the medium term, supported by improved consumer confidence, pricing strategies, and demographic trends.